Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Shares Outstanding: 2022-2025

  • Cellebrite DI's Shares Outstanding fell 57.83% to $5.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.9 million, marking a year-over-year decrease of 57.83%. This contributed to the annual value of $10.5 million for FY2024, which is 33.42% down from last year.
  • Latest data reveals that Cellebrite DI reported Shares Outstanding of $5.9 million as of Q2 2025, which was down 44.09% from $10.5 million recorded in Q4 2024.
  • In the past 5 years, Cellebrite DI's Shares Outstanding registered a high of $15.7 million during Q4 2023, and its lowest value of $5.9 million during Q2 2025.
  • In the last 3 years, Cellebrite DI's Shares Outstanding had a median value of $12.2 million in 2024 and averaged $11.5 million.
  • Data for Cellebrite DI's Shares Outstanding shows a maximum YoY slumped of 57.83% (in 2025) over the last 5 years.
  • Over the past 3 years, Cellebrite DI's Shares Outstanding (Quarterly) stood at $15.7 million in 2023, then tumbled by 33.42% to $10.5 million in 2024, then plummeted by 57.83% to $5.9 million in 2025.
  • Its Shares Outstanding stands at $5.9 million for Q2 2025, versus $10.5 million for Q4 2024 and $13.9 million for Q2 2024.